Ohtani Shoichiro, Kagawa Shunsuke, Tango Yasuhisa, Umeoka Tatsuo, Tokunaga Naoyuki, Tsunemitsu Yousuke, Roth Jack A, Taya Yoichi, Tanaka Noriaki, Fujiwara Toshiyoshi
Division of Surgical Oncology, Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Mol Cancer Ther. 2004 Jan;3(1):93-100.
To analyze the mechanism of the antitumor effect of an adenoviral vector expressing the p53 tumor suppressor (Ad-p53) in vivo, we quantitatively assessed p53-targeted gene expression and visualized transcriptional activity of p53 in tumors in nude mice treated with Ad-p53. Human lung cancer (H1299) xenografts established in nude mice were treated by intratumoral administration of Ad-p53. The levels of expression of exogenous p53 and p53-targeted genes p21, MDM2, Noxa, and p53AIP1 were quantified by real-time reverse transcription-PCR (RT-PCR) and induction of apoptosis was observed histochemically on days 1-3, 7, and 14 after treatment. Expression of mRNA of exogenous p53 and p53-targeted genes (except p53AIP1) was at its maximum 1 day after Ad-p53 treatment and then decreased rapidly; apoptosis was evident in situ 2-3 days after treatment. We developed a noninvasive and simple method for monitoring the transcriptional activity of exogenous p53 following intratumoral administration of Ad-p53 in nude mice. We established H1299 cells that express the green fluorescent protein (GFP) reporter gene under the control of p53-responsive p21 promoter (i.e., the p53R-GFP reporter system). Xenografts of these cells in nude mice were treated by intratumoral administration of Ad-p53, and the transcriptional activity of exogenous p53 could be visualized as intratumoral GFP expression in real time by 3-CCD camera. Expression of GFP was maximal 3 days after treatment and decreased remarkably by 7 days after treatment. We demonstrated that Ad-p53 treatment rapidly induced p53-targeted genes and apoptosis in tumors and succeeded in visualizing p53 transcriptional activity in vivo. We also found that Ad-p53 infection induced phosphorylation of p53 at Ser(46) in p53-sensitive H1299 cells in vitro but not in p53-resistant H226Br cells, suggesting that phosphorylation of Ser(46) is involved in p53-dependent apoptosis. Our data indicate that quantitative analysis of p53-targeted gene expression by real-time quantitative RT-PCR and visualization of p53 transcriptional activity in fresh xenografts by using the p53R-GFP reporter system may be useful in assessing the mechanisms of the antitumor effects of Ad-p53 and novel therapeutic approaches.
为分析表达p53肿瘤抑制因子的腺病毒载体(Ad-p53)在体内的抗肿瘤作用机制,我们对p53靶向基因表达进行了定量评估,并在接受Ad-p53治疗的裸鼠肿瘤中观察p53的转录活性。将人肺癌(H1299)异种移植瘤接种于裸鼠,通过瘤内注射Ad-p53进行治疗。采用实时逆转录聚合酶链反应(RT-PCR)定量检测外源性p53及p53靶向基因p21、MDM2、Noxa和p53AIP1的表达水平,并在治疗后第1 - 3天、第7天和第14天通过组织化学方法观察凋亡情况。Ad-p53治疗后1天,外源性p53及p53靶向基因(p53AIP1除外)的mRNA表达达到峰值,随后迅速下降;治疗后2 - 3天,原位凋亡明显。我们开发了一种无创且简便的方法,用于监测裸鼠瘤内注射Ad-p53后外源性p53的转录活性。我们构建了在p53反应性p21启动子控制下表达绿色荧光蛋白(GFP)报告基因的H1299细胞(即p53R-GFP报告系统)。将这些细胞接种于裸鼠形成异种移植瘤,通过瘤内注射Ad-p53进行治疗,利用3 - CCD相机可实时观察到瘤内GFP表达,以此显示外源性p53的转录活性。治疗后3天,GFP表达达到峰值,治疗后7天显著下降。我们证明Ad-p53治疗可迅速诱导肿瘤中p53靶向基因表达及凋亡,并成功在体内观察到p53转录活性。我们还发现,Ad-p53感染在体外可诱导p53敏感的H1299细胞中p53的Ser(46)位点磷酸化,但在p53耐药的H226Br细胞中则不能,这表明Ser(46)位点磷酸化参与了p53依赖的凋亡过程。我们的数据表明,通过实时定量RT-PCR对p53靶向基因表达进行定量分析,以及利用p53R-GFP报告系统在新鲜异种移植瘤中观察p53转录活性,可能有助于评估Ad-p53的抗肿瘤作用机制及新的治疗方法。